Skip to main content
TipRanks
Go Ultimate75% OFF

Lexicon Pharmaceuticals (LXRX) Ratios

1,836 Followers

Lexicon Pharmaceuticals Ratios

LXRX's free cash flow for Q3 2026 was $-8.08M. For the 2026 fiscal year, LXRX's free cash flow was increased by $0.00 and operating cash flow was $-8.08M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio4.885.445.606.084.02
Quick Ratio4.875.445.586.084.02
Cash Ratio1.641.470.712.002.90
Solvency Ratio-0.64-1.31-1.30-1.32-3.75
Operating Cash Flow Ratio-3.25-3.95-5.13-3.83-3.93
Short-Term Operating Cash Flow Coverage-10.880.000.000.000.00
Net Current Asset Value$ 24.45M$ 93.72M$ 40.23M$ 63.69M$ 65.61M
Leverage Ratios
Debt-to-Assets Ratio0.340.360.460.280.02
Debt-to-Equity Ratio0.580.741.140.470.02
Debt-to-Capital Ratio0.370.430.530.320.02
Long-Term Debt-to-Capital Ratio0.310.410.520.290.00
Financial Leverage Ratio1.722.042.461.661.21
Debt Service Coverage Ratio-2.84-11.83-12.96-35.98-108.23
Interest Coverage Ratio-5.87-12.65-13.11-36.24-108.59
Debt to Market Cap0.130.420.290.150.00
Interest Debt Per Share0.190.390.540.350.02
Net Debt to EBITDA-0.67-0.23-0.49-0.090.71
Profitability Margins
Gross Profit Margin99.45%98.02%-4798.01%-37681.29%-18371.81%
EBIT Margin-84.34%-594.65%-14145.35%-72273.38%-29224.83%
EBITDA Margin-83.09%-592.93%-14099.34%-71966.19%-29126.85%
Operating Profit Margin-98.21%-634.20%-14264.95%-72489.21%-29224.83%
Pretax Profit Margin-101.08%-644.78%-14710.88%-73341.01%-29448.99%
Net Profit Margin-101.08%-644.78%-14710.88%-73341.01%-29448.99%
Continuous Operations Profit Margin-101.08%-644.78%-14710.88%-73341.01%-29448.99%
Net Income Per EBT100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT102.92%101.67%103.13%101.18%100.77%
Return on Assets (ROA)-27.21%-67.15%-77.20%-52.47%-64.10%
Return on Equity (ROE)-46.81%-137.31%-190.23%-87.04%-77.26%
Return on Capital Employed (ROCE)-29.80%-77.86%-86.79%-58.88%-75.87%
Return on Invested Capital (ROIC)-28.71%-77.50%-86.23%-58.44%-75.16%
Return on Tangible Assets-35.84%-78.94%-95.80%-68.07%-95.01%
Earnings Yield-12.06%-84.79%-52.35%-32.20%-15.29%
Efficiency Ratios
Receivables Turnover20.898.951.194.9621.29
Payables Turnover0.090.044.105.056.01
Inventory Turnover0.982.67154.780.000.00
Fixed Asset Turnover5.424.250.160.020.09
Asset Turnover0.270.100.010.000.00
Working Capital Turnover Ratio0.350.180.010.000.00
Cash Conversion Cycle-3715.12-8592.41219.491.28-43.54
Days of Sales Outstanding17.4740.79306.1973.5317.15
Days of Inventory Outstanding374.32136.882.360.000.00
Days of Payables Outstanding4106.928770.0789.0672.2560.69
Operating Cycle391.80177.66308.5573.5317.15
Cash Flow Ratios
Operating Cash Flow Per Share-0.19-0.56-0.73-0.54-0.60
Free Cash Flow Per Share-0.19-0.56-0.73-0.54-0.61
Dividend Paid and CapEx Coverage Ratio0.00-173.40-344.46-67.01-71.27
Capital Expenditure Coverage Ratio0.00-173.40-344.46-67.01-71.27
Operating Cash Flow Coverage Ratio-1.09-1.65-1.53-1.61-38.18
Operating Cash Flow to Sales Ratio-1.36-5.75-134.47-639.22-292.00
Free Cash Flow Yield-16.25%-76.08%-47.99%-28.49%-15.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-8.21-1.17-1.91-3.11-6.54
Price-to-Sales (P/S) Ratio8.387.60281.002277.341925.73
Price-to-Book (P/B) Ratio3.881.623.632.705.05
Price-to-Free Cash Flow (P/FCF) Ratio-6.15-1.31-2.08-3.51-6.50
Price-to-Operating Cash Flow Ratio-6.15-1.32-2.09-3.56-6.59
Price-to-Earnings Growth (PEG) Ratio0.110.06-0.07-1.892.06
Enterprise Value Multiple-10.76-1.51-2.49-3.25-5.90
Enterprise Value445.42M278.08M421.93M325.50M512.08M
EV to EBITDA-10.76-1.51-2.49-3.25-5.90
EV to Sales8.948.95350.442341.721718.40
EV to Free Cash Flow-6.56-1.55-2.60-3.61-5.80
EV to Operating Cash Flow-6.56-1.56-2.61-3.66-5.88
Tangible Book Value Per Share0.170.320.220.440.47
Shareholders’ Equity Per Share0.300.460.420.710.78
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share0.140.100.010.000.00
Net Income Per Share-0.14-0.63-0.80-0.62-0.60
Tax Burden1.001.001.001.001.00
Interest Burden1.201.081.041.011.01
Research & Development to Revenue1.232.7248.91379.97184.72
SG&A to Revenue0.754.240.000.000.00
Stock-Based Compensation to Revenue0.250.4311.9182.8835.49
Income Quality1.350.890.910.870.99

Currency in USD